Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study. - Wikidata - awgldk - TriplyDB

Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.

Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.

http://www.wikidata.org/entity/Q35286318

about

Do studies reporting 'U'-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects?The Use of 1α,25-Dihydroxyvitamin D₃ as an Anticancer Agent Vitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological Evidence Vitamin D and Immune Response: Implications for Prostate Cancer in African Americans Lifestyle and dietary factors in the prevention of lethal prostate cancer Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Vitamin D and extra-skeletal health: causality or consequence Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial.Applying the precautionary principle to nutrition and cancer.Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade Prospective study of ultraviolet radiation exposure and risk of cancer in the United States Vitamin D transport proteins megalin and disabled-2 are expressed in prostate and colon epithelial cells and are induced and activated by all-trans-retinoic acid A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D2) in patients with advanced cancer.Association between Plasma 25-Hydroxyvitamin D, Ancestry and Aggressive Prostate Cancer among African Americans and European Americans in PCaP Both serum 25-hydroxyvitamin D and calcium levels may increase the risk of incident prostate cancer in Caribbean men of African ancestry.Vitamin D and Cancer: Diversity, Complexity, and Still a Ways to Go Risk of prostate cancer in African-American men: Evidence of mixed effects of dietary quercetin by serum vitamin D status.Long Term Association between Serum 25-Hydroxyvitamin D and Mortality in a Cohort of 4379 Men Dietary supplements and cancer prevention: balancing potential benefits against proven harms.Race and BMI modify associations of calcium and vitamin D intake with prostate cancer Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological study.Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.Circulating 25-Hydroxyvitamin D and Prostate Cancer Survival.Pigmentation-related phenotypes and risk of prostate cancer.Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men.Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma.Interactions of the Insulin-Like Growth Factor Axis and Vitamin D in Prostate Cancer Risk in the Prostate Cancer Prevention Trial.Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3.Overview of Dietary Supplements in Prostate Cancer.Plasma 25-hydroxy vitamin D and subsequent prostate cancer risk in a nested Case-Control study in Japan: The JPHC study.Vitamins, metabolomics, and prostate cancer.Metabolomics analysis of serum 25-hydroxy-vitamin D in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.Vitamin D, PTH, and calcium in relation to survival following prostate cancer.A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial.Predicting vitamin D deficiency in older Australian adults.Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.Can vitamin D supplementation reduce prostate cancer disparities?Circulating vitamin D concentration and risk of prostate cancer: a dose-response meta-analysis of prospective studies.

P2860

Q26739511-A6C88119-5F6B-4DFF-9A2C-9A99743D255C Q26749030-5B4D8D54-D09D-4763-978A-AD8AC301EB7E Q26766256-D57A3066-767F-4067-9B0A-4AFC9443D3EF Q26768536-1C1F6431-FB72-47E1-A013-4D7C169CE184 Q27025735-C25CE9C3-693B-4216-9BE4-8B6048C69E9D Q27336054-35F06175-E111-4454-9495-536D37166EB2 Q28066698-715CC8B4-9706-4D17-A271-076FEDE8A919 Q33992150-D533196D-A660-491B-9B4E-35FA186BAD45 Q34041094-1AF71A38-52A7-4AE8-BBF9-7EC9C0A54A46 Q34228158-689DD411-3AC8-45A5-BFE6-45716C4D00CB Q34271258-512BA6FE-38BA-4A6A-B524-29148E463CB7 Q34541761-F96B8D84-4DF0-4794-99D8-7E502385AE1D Q34799393-86AE6BD5-46CE-466C-9CF4-42969106D45C Q35546959-3FED5C9D-01AE-471F-904B-F3FA4D8C573E Q35755412-7104324C-FE1B-443F-AF2A-596AFB7967B2 Q35925081-818A9696-C4B7-486F-A5E7-78FE3A43C307 Q35952018-BF291B00-7202-4BA6-9285-8DFB569ED310 Q35961214-DE09C3F0-705D-4E65-ADE1-5E00A4F93BBD Q35962084-F7FC8626-6917-4D9E-A5FA-F9B506B69C24 Q36254438-1BAAE212-07AC-4BE1-9EAA-A97BBD90D00B Q36476562-CACFAC09-E891-4933-B575-529390A4D0BF Q36674846-1ADC46B1-4E20-456A-B48A-F594994AAE3E Q36741744-21EC24A6-FA48-471A-A3BB-05D901E99CDA Q36917872-43BED36B-7EC1-408A-9DDD-2DCF68304CE5 Q37081867-68203484-8175-40B9-BDCF-FFDD04780752 Q37628321-52182E46-B019-4665-AC5C-B0DA3829B5CB Q37649866-7E5976A7-D6A0-40DB-BB08-45A315357657 Q38832987-64DA2819-3A6D-48A2-9816-E3F9A7ABB3D7 Q38842066-6159408C-2173-49E2-B996-B9B477580957 Q38950685-29ABBFF9-B220-4D27-A667-ACA48BB587F8 Q39272197-3E940FBB-BC0F-49F2-973A-557760ADA4EF Q39658509-35BA3EC6-B0E4-47F9-A677-63C2D1957575 Q40622136-6832A8E0-3D31-4B02-AAFD-5198BEF6A11B Q40829133-D525B4A8-AF1F-4C5D-80C9-8691463D445C Q41122869-9810D4C4-CFCE-44C6-9295-B4FD28CDC2EB Q42766017-34FF0907-FF0B-4198-AAB5-9D6FC7D9D544 Q44022876-24E5E1BA-98C6-4D59-B55E-5C15CBA08E58 Q45071502-52A1D98A-DB45-49D7-9D28-1D0C9B811C78 Q46658342-F836B2E7-39D9-4061-B183-EC0EB80F406C Q49540308-62F54870-D487-4870-9088-4B5B1F67AC1D

P2860

Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.

http://www.wikidata.org/entity/Q35286318

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.

@ast

Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.

@en

type

label

Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.

@ast

Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.

@en

prefLabel

Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.

@ast

Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.

@en

P1433

Q35286318-940FB320-3EC7-4CFC-B574-9372137D6AB5

P1476

Q35286318-435C1D98-523B-4CBF-A61E-481C83DC7911

P2093

Q35286318-4139D71D-CE48-4363-8C1B-95B32289E57A

Q35286318-AAA1FEEB-0765-4D38-AA52-285C00378420

Q35286318-AE13334C-2945-42F4-A455-9CCA8C92EF39

Q35286318-D1286FF1-18A3-46BC-8984-75DBC2C7537E

P2860

Q35286318-04525A14-69AE-40FB-BB1C-B1B40D1002AE

Q35286318-06E2546C-9056-40EB-B421-D6366902F330

Q35286318-09F18FE4-8946-4220-B00C-E141D8B6E382

Q35286318-09FCF289-5008-429B-ACA8-329DCA634C02

Q35286318-0E15A78C-7542-483E-8388-A03DA445911A

Q35286318-10100403-E745-420A-B817-EB7370413F96

Q35286318-183D939A-6F6D-4374-80FD-16E469FA3DBA

Q35286318-1F7D93F6-BD51-43EC-84EC-851A97333EFA

Q35286318-23F924CA-532F-4F65-A017-D40B80505C12

Q35286318-2783E188-EA6B-43BE-ABBF-9D393C249C28

P304

Q35286318-66429AFB-2E66-4F51-8D9F-4D81C20577D0

P31

Q35286318-CC947934-D6BC-4567-9B0D-48C38C1FC51E

P356

Q35286318-E62F1BA7-BE86-40E2-96F0-131BBC816932

P433

Q35286318-BF1E976E-FA8F-4FBE-9143-92F7190FE73A

P478

Q35286318-3637A654-2284-413F-A110-282CA4C0BBA9

P50

Q35286318-3C62E690-FD50-4755-B734-AB72529634AA

Q35286318-8D13B0D6-8BC3-489C-B011-6C39B8C7E37D

Q35286318-C9C22657-6111-478F-9765-644FBA5A2363

P577

Q35286318-9010A41B-186F-4A09-AF53-0890493DE640

P5875

Q35286318-11ECF60C-2140-443B-813A-BFBED7B2773B

P698

Q35286318-AE6EC147-41E6-4729-AF71-BA28B128241B

P921

Q35286318-4F928713-B196-48A7-8CE3-7B305B63947F

P932

Q35286318-361880FD-4158-4AD8-8DD0-315E0B642B2D

P356

1055-9965.EPI-11-0403

P1433

Cancer Epidemiology, Biomarkers & Prevention

P1476

Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.

@en

P2093

Dominick Parisi

http://www.w3.org/2001/XMLSchema#string

Kai Yu

http://www.w3.org/2001/XMLSchema#string

Ronald L Horst

http://www.w3.org/2001/XMLSchema#string

Stephanie J Weinstein

http://www.w3.org/2001/XMLSchema#string

P2860

Common genetic determinants of vitamin D insufficiency: a genome-wide association study

Molecular actions of vitamin D contributing to cancer prevention

Vitamin D deficiency

A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

Plasma 25-hydroxyvitamin D and prostate cancer risk: the multiethnic cohort.

Estimation of total usual calcium and vitamin D intakes in the United States.

Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Genome-wide association study of circulating vitamin D levels.

Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

P304

1850-1860

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1055-9965.EPI-11-0403

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Demetrius Albanes

Alison M Mondul

P577

2011-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51517256

http://www.w3.org/2001/XMLSchema#string

P698

21784952

http://www.w3.org/2001/XMLSchema#string

P921

P932

3188814

http://www.w3.org/2001/XMLSchema#string